The International Journal of Gynecological Cancer (IJGC) is the official scientific journal of the International Gynecologic Cancer Society (IGCS) and the European Society of Gynaecological Oncology (ESGO). It is a leading scientific journal in the field of gynecologic oncology and is seeking a dynamic and visionary individual to serve as its next Editor-in-Chief.
This prestigious role offers the opportunity to shape the journal’s future and contribute significantly to advancing knowledge and innovation in the field of Gynecologic Oncology.
About IJGC
- Publishes articles relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies.
- The readership includes gynecologists, medical and radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecologic cancers.
- 2023 Impact Factor of IJGC was 4.5.
- Currently published by Elsevier comprising approximately 12 issues per year and a number of supplements.
Search for next Editor-in-Chief
Candidates should possess strong leadership qualities, intellectual vision, high international standing in the field of Gynaecological Oncology, and experience relevant to editing a leading medical journal. Candidates must possess excellent communication, organizational and interpersonal skills, have a wide network of international professional contacts and a strong proficiency in English.
As the journal of the ESGO and IGCS Societies, the Editor-in-Chief will work closely with the Societies’ Journal Committee and publish congress proceedings of the Societies and other high quality educational work. The Editor-in-Chief and journal operations are supported by a managing editor.
The new Editor-in-Chief will officially assume responsibility for the Journal on January 1, 2027, but must be prepared to help facilitate the editorial transition beginning on August 1, 2026, working with Prof. Ramirez as a proleptic Editor-in-Chief. The initial term is 5 years (2027-2032), with the possibility of an extension.
International Journal of Gynecological Cancer (IJGC) Call for Editor-in-Chief
The International Journal of Gynecological Cancer (IJGC) is the official scientific journal of the International Gynecologic Cancer Society (IGCS) and the European Society of Gynaecological Oncology (ESGO). It is a leading scientific journal in the field of gynecologic oncology and is seeking a dynamic and visionary individual to serve as its next Editor-in-Chief.
This prestigious role offers the opportunity to shape the journal’s future and contribute significantly to advancing knowledge and innovation in the field of Gynecologic Oncology.
About IJGC
- Publishes articles relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies.
- The readership includes gynecologists, medical and radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecologic cancers.
- 2023 Impact Factor of IJGC was 4.5.
- Currently published by Elsevier comprising approximately 12 issues per year and a number of supplements.
Search for next Editor-in-Chief
Candidates should possess strong leadership qualities, intellectual vision, high international standing in the field of Gynaecological Oncology, and experience relevant to editing a leading medical journal. Candidates must possess excellent communication, organizational and interpersonal skills, have a wide network of international professional contacts and a strong proficiency in English.
As the journal of the ESGO and IGCS Societies, the Editor-in-Chief will work closely with the Societies’ Journal Committee and publish congress proceedings of the Societies and other high quality educational work. The Editor-in-Chief and journal operations are supported by a managing editor.
The new Editor-in-Chief will officially assume responsibility for the Journal on January 1, 2027, but must be prepared to help facilitate the editorial transition beginning on August 1, 2026, working with Prof. Ramirez as a proleptic Editor-in-Chief. The initial term is 5 years (2027-2032), with the possibility of an extension.